Journal of hepatology

Keyphrases

Publications

volume 81, number 3, 2024

null null, null null, null null, null null
EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Journal of hepatology 81 (3) (2024)
Bing Zhu, Yibing Guo, Sa Lv, Xiuxin Ling, Shaoli You
Hepatic phenotypes of EFL1-related Shwachman-Diamond syndrome in a biopsy-validated study. Journal of hepatology 81 (3) (2024)
Isabelle Ollivier-Hourmand, Louise Lebedel, Berta Bartroli Alabau, Odile Goria, Christophe Bureau, Jérome Dumortier, Alexandra Heurgué, Christine Silvain, Victor De-Ledinghen, Pierre-Emmanuel Rautou, Audrey Payancé, Teresa García Ballester, Edilmar Alvarado-Tapias, Virginia Hernández-Gea, Dominique Valla, Kamal Zekrini, Thi Thu Nga Nguyen, Thong Dao, Juan Carlos Garcia Pagan, Rémy Morello, Aurélie Plessier
Recurrent splanchnic and extrasplanchnic thrombotic events in patients with non-cirrhotic portal vein thrombosis associated with local factors. Journal of hepatology 81 (3) (2024)
Yang Li, FengQi Yang, Kai Liu
Application of digital pathology in liver transplantation. Journal of hepatology 81 (3) (2024)
Congyun Liu, Cheng Guo, Kai Liu
Changes of hepatic myeloid cells in chronic viral hepatitis and after cure and their clinical significance. Journal of hepatology 81 (3) (2024)
Alan C Kwan, Minhao Wang, Hirsh D Trivedi, Hongwei Ji, Susan Cheng
Sex-specific associations of steatotic liver disease with vascular health. Journal of hepatology 81 (3) (2024)
Maxime Ronot
Improving HCC surveillance with abbreviated MRI: A call to integrate and innovate? Journal of hepatology 81 (3) (2024)
Anna Bertolini, Mytien Nguyen, Syeda Andleeb Zehra, Shakila Afroz Taleb, Tory Bauer-Pisani, Noah Palm, Mario Strazzabosco, Romina Fiorotto
Prominent role of gut dysbiosis in the pathogenesis of cystic fibrosis-related liver disease in mice. Journal of hepatology 81 (3) (2024)
Mo-Yao Tan, Xiang-Long Zhai
Primary hypobetalipoproteinemia as a risk factor for liver complications. Journal of hepatology 81 (3) (2024)
Jia-Lin Wu, Jun-Yang Luo, Zai-Bo Jiang
Association between antiviral treatments and fracture in elderly patients with HBV needs further evaluation. Journal of hepatology 81 (3) (2024)
Xing Wang, Qiuhe Wang, Zhengyu Wang, Bohan Luo, Guohong Han
Post-TIPS OHE: Are we really making a mountain out of a molehill? Journal of hepatology 81 (3) (2024)
Andrea Pasta, Giulia Pieri, Maria Corina Plaz Torres, Franco Trevisani, Edoardo G Giannini, null null
Hepatocellular carcinoma in patients with autoimmune hepatitis. Journal of hepatology 81 (3) (2024)
Jean de Ville de Goyet
Tailoring allocation policies and improving access to pediatric liver transplantation in Italy: Outframing and concluding. Journal of hepatology 81 (3) (2024)
Elisa Allen, Rhiannon Taylor, Alexander Gimson, Douglas Thorburn
Transplant benefit-based offering of deceased donor livers in the United Kingdom. Journal of hepatology 81 (3) (2024)
Jimmy Che-To Lai, Terry Cheuk-Fung Yip, Grace Lai-Hung Wong
Reply to: "Association between antiviral treatments and fracture in elderly patients with HBV needs further evaluation". Journal of hepatology 81 (3) (2024)
Marco Spada, Roberta Angelico, Silvia Trapani, Lucia Masiero, Francesca Puoti, Michele Colledan, Davide Cintorino, Renato Romagnoli, Umberto Cillo, Massimo Cardillo
Reply to: "Tailoring allocation policies and improving access to pediatric liver transplantation in Italy: Outframing and concluding". Journal of hepatology 81 (3) (2024)
Umberto Cillo, Federico Nalesso, Alessandra Bertacco, Stefano Indraccolo, Enrico Gringeri
Normothermic perfusion of a human tumoral liver for 17 days with concomitant extracorporeal blood purification therapy: Case description. Journal of hepatology 81 (3) (2024)
Matthieu Wargny, Bertrand Cariou
Reply to: "Primary hypobetalipoproteinemia as a risk factor for liver complications". Journal of hepatology 81 (3) (2024)
Kosh Agarwal, Maria Buti, Florian van Bömmel, Pietro Lampertico, Ewa Janczewska, Marc Bourliere, Thomas Vanwolleghem, Oliver Lenz, Thierry Verbinnen, Thomas N Kakuda, Cristiana Mayer, John Jezorwski, Daniel Muenz, Maria Beumont, Ronald Kalmeijer, Michael Biermer, Isabelle Lonjon-Domanec
JNJ-73763989 and bersacapavir treatment in nucleos(t)ide analogue-suppressed patients with chronic hepatitis B: REEF-2. Journal of hepatology 81 (3) (2024)
Alexander P Underwood, Money Gupta, Bing-Ru Wu, Auda A Eltahla, Irene Boo, Jing Jing Wang, David Agapiou, Arunasingam Abayasingam, Arnold Reynaldi, Elizabeth Keoshkerian, Yanran Zhao, Nicholas Brasher, Melanie R Walker, Jens Bukh, Lisa Maher, Tom Gordon, Miles P Davenport, Fabio Luciani, Heidi E Drummer, Andrew R Lloyd, Rowena A Bull
B-cell characteristics define HCV reinfection outcome. Journal of hepatology 81 (3) (2024)
Xing Wang, Qiuhe Wang, Zhengyu Wang, Bohan Luo, Guohong Han
Post-TIPS OHE: Are we really making a mountain out of a molehill? Journal of hepatology 81 (3) (2024)
Dong Hwan Kim, Jeong Hee Yoon, Moon Hyung Choi, Chang Hee Lee, Tae Wook Kang, Hyun A Kim, Young-Mi Ku, Jeong Min Lee, Seong Hyun Kim, Kyung Ah Kim, Su Lim Lee, Joon-Il Choi
Comparison of non-contrast abbreviated MRI and ultrasound as surveillance modalities for HCC. Journal of hepatology 81 (3) (2024)
Elisa Allen, Rhiannon Taylor, Alexander Gimson, Douglas Thorburn
Transplant benefit-based offering of deceased donor livers in the United Kingdom. Journal of hepatology 81 (3) (2024)
Andrea Pasta, Giulia Pieri, Maria Corina Plaz Torres, Franco Trevisani, Edoardo G Giannini, null null
Hepatocellular carcinoma in patients with autoimmune hepatitis. Journal of hepatology 81 (3) (2024)
Dan Shan
Expanding the dialogue: A closer look at AIH management and HCC risk. Journal of hepatology 81 (3) (2024)
Mo-Yao Tan, Xiang-Long Zhai
Primary hypobetalipoproteinemia as a risk factor for liver complications. Journal of hepatology 81 (3) (2024)
Anna Bertolini, Mytien Nguyen, Syeda Andleeb Zehra, Shakila Afroz Taleb, Tory Bauer-Pisani, Noah Palm, Mario Strazzabosco, Romina Fiorotto
Prominent role of gut dysbiosis in the pathogenesis of cystic fibrosis-related liver disease in mice. Journal of hepatology 81 (3) (2024)
Jia-Lin Wu, Jun-Yang Luo, Zai-Bo Jiang
Association between antiviral treatments and fracture in elderly patients with HBV needs further evaluation. Journal of hepatology 81 (3) (2024)
Vincent L Chen, Xiaomeng Du, Antonino Oliveri, Yanhua Chen, Annapurna Kuppa, Brian D Halligan, Michael A Province, Elizabeth K Speliotes
Genetic risk accentuates dietary effects on hepatic steatosis, inflammation and fibrosis in a population-based cohort. Journal of hepatology 81 (3) (2024)
Ann Thu Ma, Cristina Solé, Adrià Juanola, Laia Escudé, Laura Napoleone, Emma Avitabile, Martina Pérez-Guasch, Marta Carol, Enrico Pompili, Jordi Gratacós-Ginés, Anna Soria, Ana Belén Rubio, Marta Cervera, Maria José Moreta, Manuel Morales-Ruiz, Elsa Solà, Esteban Poch, Núria Fabrellas, Isabel Graupera, Elisa Pose, Pere Ginès
Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis. Journal of hepatology 81 (3) (2024)
Dan Shan
Expanding the dialogue: A closer look at AIH management and HCC risk. Journal of hepatology 81 (3) (2024)
Guilherme Grossi Lopes Cançado, Maya Deeb, David Dodington, Gideon Morris Hirschfield
The liver in haematologic oncologic disorders. Journal of hepatology 81 (3) (2024)
Kosh Agarwal, Maria Buti, Florian van Bömmel, Pietro Lampertico, Ewa Janczewska, Marc Bourliere, Thomas Vanwolleghem, Oliver Lenz, Thierry Verbinnen, Thomas N Kakuda, Cristiana Mayer, John Jezorwski, Daniel Muenz, Maria Beumont, Ronald Kalmeijer, Michael Biermer, Isabelle Lonjon-Domanec
JNJ-73763989 and bersacapavir treatment in nucleos(t)ide analogue-suppressed patients with chronic hepatitis B: REEF-2. Journal of hepatology 81 (3) (2024)
Alessandro Gambella, Massimo Salvi, Filippo Molinari
Reply to: "Application of digital pathology in liver transplantation". Journal of hepatology 81 (3) (2024)
Jinhang Gao, Tian Lan, Enis Kostallari, Yangkun Guo, Enjiang Lai, Adrien Guillot, Bisen Ding, Frank Tacke, Chengwei Tang, Vijay H Shah
Angiocrine signaling in sinusoidal homeostasis and liver diseases. Journal of hepatology 81 (3) (2024)
Silvia Nardelli, Francesco Vizzutti, Fabio Marra, Filippo Schepis, Oliviero Riggio
Reply to: "Post-TIPS OHE: Are we really making a mountain out of a molehill?" Journal of hepatology 81 (3) (2024)
Francesca Colapietro, Ana Lleo
Correspondence on "Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis". Journal of hepatology 81 (3) (2024)
Linfeng He, Wenbin Zheng, Yunfei Liao, Wen Kong, Tianshu Zeng
Individuals with cardiometabolic risk factors are at higher risk for early-onset NAFLD. Journal of hepatology 81 (3) (2024)
Stephen A Harrison, Tim Rolph, Madeline Knott, Julie Dubourg
FGF21 agonists: An emerging therapeutic for metabolic dysfunction-associated steatohepatitis and beyond. Journal of hepatology 81 (3) (2024)
Hanyun Tu
A closer look at the innovative PAGED-B score. Journal of hepatology 81 (3) (2024)
Kuangyang Chen, Yahao Wang, Jia Yang, Nora Klöting, Chuanfeng Liu, Jiarong Dai, Shuoshuo Jin, Lijiao Chen, Shan Liu, Yuzhao Liu, Yongzhuo Yu, Xiaoxia Liu, Qing Miao, Chong Wee Liew, Yangang Wang, Arne Dietrich, Matthias Blüher, Xuanchun Wang
EMC10 modulates hepatic ER stress and steatosis in an isoform-specific manner. Journal of hepatology 81 (3) (2024)
Vincent L Chen, Xiaomeng Du, Antonino Oliveri, Yanhua Chen, Annapurna Kuppa, Brian D Halligan, Michael A Province, Elizabeth K Speliotes
Genetic risk accentuates dietary effects on hepatic steatosis, inflammation and fibrosis in a population-based cohort. Journal of hepatology 81 (3) (2024)
Kuangyang Chen, Yahao Wang, Jia Yang, Nora Klöting, Chuanfeng Liu, Jiarong Dai, Shuoshuo Jin, Lijiao Chen, Shan Liu, Yuzhao Liu, Yongzhuo Yu, Xiaoxia Liu, Qing Miao, Chong Wee Liew, Yangang Wang, Arne Dietrich, Matthias Blüher, Xuanchun Wang
EMC10 modulates hepatic ER stress and steatosis in an isoform-specific manner. Journal of hepatology 81 (3) (2024)
Jean de Ville de Goyet
Tailoring allocation policies and improving access to pediatric liver transplantation in Italy: Outframing and concluding. Journal of hepatology 81 (3) (2024)
Dong Hwan Kim, Jeong Hee Yoon, Moon Hyung Choi, Chang Hee Lee, Tae Wook Kang, Hyun A Kim, Young-Mi Ku, Jeong Min Lee, Seong Hyun Kim, Kyung Ah Kim, Su Lim Lee, Joon-Il Choi
Comparison of non-contrast abbreviated MRI and ultrasound as surveillance modalities for HCC. Journal of hepatology 81 (3) (2024)
Alexander P Underwood, Money Gupta, Bing-Ru Wu, Auda A Eltahla, Irene Boo, Jing Jing Wang, David Agapiou, Arunasingam Abayasingam, Arnold Reynaldi, Elizabeth Keoshkerian, Yanran Zhao, Nicholas Brasher, Melanie R Walker, Jens Bukh, Lisa Maher, Tom Gordon, Miles P Davenport, Fabio Luciani, Heidi E Drummer, Andrew R Lloyd, Rowena A Bull
B-cell characteristics define HCV reinfection outcome. Journal of hepatology 81 (3) (2024)
Jiang-Tao Fu, Jian Liu, Wen-Bin Wu, Yi-Ting Chen, Guo-Dong Lu, Qi Cao, Hong-Bo Meng, Jie Tong, Jia-Hui Zhu, Xu-Jie Wang, Yi Liu, Chunlin Zhuang, Chunquan Sheng, Fu-Ming Shen, Xingguang Liu, Hua Wang, Yongsheng Yu, Yuefan Zhang, Hai-Yan Liang, Jia-Bao Zhang, Dong-Jie Li, Xiang Li, Zhi-Bin Wang, Pei Wang
Targeting EFHD2 inhibits interferon-γ signaling and ameliorates non-alcoholic steatohepatitis. Journal of hepatology 81 (3) (2024)
Yang Li, FengQi Yang, Kai Liu
Application of digital pathology in liver transplantation. Journal of hepatology 81 (3) (2024)

volume 81, number 4, 2024

Michael Talanian, Mohammad Almeqdadi, Hannah H Chen
From dark bile to bright insight: A liver biopsy with advanced fibrosis and severe cholestasis. Journal of hepatology 81 (4) (2024)
Patrizia Burra, Frank Tacke, Vlad Ratziu, Stefan Zeuzem, Bruno Sangro, Paolo Angeli
From the Editor's Desk... Journal of hepatology 81 (4) (2024)